Private Credit Lures the Ultra-Rich Sitting on $3.1 Trillion
'We like selective parts of alternative credit,' said Harinder Hundle, managing partner of multi-family office Hundle, on a panel at the London Private Markets Meeting. 'We can see it generates yield and income for investors and that's great in the current environment.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
25 minutes ago
- Washington Post
Trump wields tariffs to sway Putin on Ukraine. Here's how they might work, or not
WASHINGTON — Russian President Vladimir Putin has sacrificed an estimated 1 million of his soldiers , killed and wounded, in a three-year campaign to crush Ukraine. Now President Donald Trump is betting that his go-to economic weapon — tariffs — can succeed where Ukrainian drones and rockets haven't, and finally persuade Putin to end his war.
Yahoo
44 minutes ago
- Yahoo
Tesla Is in Serious Trouble in China
As its sales continue to crater in the US and Europe, Tesla's reliance on China — its second-largest market and biggest production hub — is growing. But thanks to a surge in far more price-competitive and lucrative offerings from Chinese EV manufacturers like BYD, Tesla's woes look poised to metastasize there as well. Its market share in China is shrinking, the Wall Street Journal reports, which could represent yet another nail in Elon Musk's carmaker's coffin. The company sold 40,000 fewer cars in China in May, a massive 30 percent drop from the same month last year, a familiar story that's been playing out in many other parts of the world. Then there's Musk's highly damaging embrace of far-right ideologies, which have iced over the brand's popularity in huge swaths of the world. "Tesla remains important for China," a consultant for Chinese officials told the WSJ. "But for authorities, helping domestic companies still matters more." While "you never want to bet against Elon Musk and the resilience of Tesla," Musk is "probably closer to sunset than sun up in his business in China," former General Motors exec Michael Dunne added. Tesla could soon end up suffering the same fate as many other American tech companies, including Motorola and Apple, which once enjoyed enormous success in China — only to be lapped by better tech and domestically oriented regulations. "Teslas are almost like iPhones now," 34-year-old Qian Yang, who sold his Tesla Model 3 in favor of a Xiaomi SU7 EV, told the WSJ. "They're getting uninspired and stale, and don't have revolutionary features anymore." Tesla has also been facing steep regulatory hurdles getting its controversial and misleadingly-named "Full Self-Driving" driver assistance software approved in China. Beijing has yet to issue full approval, giving Chinese companies more time to catch up. However, that hasn't stopped the Musk-led company from rolling out the software anyway, per the WSJ, which has angered officials there. Musk has also reportedly ditched plans for a new car design that would be more amenable to Chinese consumers, instead focusing the company's efforts on cutting corners to save costs. The trend couldn't come at a worse time for Tesla, which has been feeling the hurt under Musk's absentee leadership. His most recent promise to create a third US political party — months after promising he was done with politics for good — has spooked investors, wiping out tens of billions of dollars in market cap. To experts, Musk simply didn't play his cards right, failing to predict Tesla could easily be overlapped in its second most important market. Even the company's Optimus humanoid robot — which Musk sees as Tesla's future alongside robotaxis — already has some intense competition in China, despite being many years from hitting markets. "He made the same mistake that every foreign automaker made — to underestimate China's ability to out-innovate you," China-based strategy firm Automobility CEO Bill Russo told the WSJ. More on Tesla: Musk Is Struggling to Understand What's Happening Around Him, Says Former Tesla Exec
Yahoo
an hour ago
- Yahoo
Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the second quarter 2025 after market close on Tuesday, August 5, 2025. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the 'Investors' section of the company website at: The webcast will be archived and available for replay within 24 hours after the event. About Adaptive Biotechnologies Adaptive Biotechnologies ('we' or 'our') is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature's most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business segments: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer and autoimmune disorders. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient. ADAPTIVE INVESTORSKarina Calzadilla, Vice President, Investor Relations and FP&A201-396-1687investors@ ADAPTIVE MEDIAErica Jones, Associate Corporate Communications Director206-279-2423media@
